Cargando…

The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer

Despite modern advances in cancer medicine, pancreatic cancer survival remains unchanged at just 12%. For the small proportion of patients diagnosed with ‘early’ (upfront or borderline resectable) disease, recurrences are common, and many recur soon after surgery. Whilst chemotherapy has been shown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maloney, Sarah, Clarke, Stephen J., Sahni, Sumit, Hudson, Amanda, Colvin, Emily, Mittal, Anubhav, Samra, Jaswinder, Pavlakis, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587199/ https://www.ncbi.nlm.nih.gov/pubmed/37460806 http://dx.doi.org/10.1007/s00432-023-05149-4

Ejemplares similares

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2020)

Drain fluid biomarkers for prediction and diagnosis of clinically relevant postoperative pancreatic fistula: A narrative review
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2022)

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer
por: Nahm, Christopher B., et al.
Publicado: (2022)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis
por: Maloney, Sarah, et al.
Publicado: (2021)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Drain fluid biomarkers for the diagnosis of clinically relevant postoperative pancreatic fistula: a diagnostic accuracy systematic review and meta-analysis
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2023)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients’ survival
por: Jambor, Maxwell A., et al.
Publicado: (2022)

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
por: Byeon, Sooin, et al.
Publicado: (2023)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

Diagnostic Accuracy of Imaging Modalities in the Evaluation of Vascular Invasion in Pancreatic Adenocarcinoma: A Meta-Analysis
por: Li, Angela E., et al.
Publicado: (2013)

Postoperative pancreatic fistula: a review of traditional and emerging concepts
por: Nahm, Christopher B, et al.
Publicado: (2018)

Surgical management of high-grade pancreatic injuries: Insights from a high-volume pancreaticobiliary specialty unit
por: Chui, Juanita Noeline, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)
por: Wong, Matthew H., et al.
Publicado: (2016)

Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis
por: Stephenson, David, et al.
Publicado: (2017)

Synchronous Operable Pancreatic and Breast Cancer Without Genetic Mutation: A Literature Review and Discussion
por: Ofri, Adam, et al.
Publicado: (2022)

Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma
por: Park, Woo Daniel, et al.
Publicado: (2015)

Do you get the GIST? Successful resection of a giant 3.5 kg gastrointestinal stromal tumour
por: Borruso, Luca, et al.
Publicado: (2022)

Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
por: Brown, Kai M., et al.
Publicado: (2016)

Anatomy of the neural fibers at the superior mesenteric artery—a cadaver study
por: Reinehr, Michael D., et al.
Publicado: (2022)

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
por: Chan, David LH, et al.
Publicado: (2017)

Safety and Efficacy of Pancreaticoduodenectomy in Octogenarians
por: Huang, Yeqian, et al.
Publicado: (2021)

Granular cell tumour of the pancreas: a case report and systematic review
por: Tree, Kevin, et al.
Publicado: (2023)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer
por: Kunovsky, Lumir, et al.
Publicado: (2018)

Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
por: Khomiak, Andrii, et al.
Publicado: (2020)

Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases
por: Brown, Kai M., et al.
Publicado: (2021)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
por: Giannis, Dimitrios, et al.
Publicado: (2021)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
por: Li, Le, et al.
Publicado: (2016)

An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
por: Yang, Zhi-Qiang, et al.
Publicado: (2020)

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Su, Qiang, et al.
Publicado: (2018)

Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer
por: Pang, Li, et al.
Publicado: (2016)

Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers
por: Moro, Loredana
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c03ee5pbeku4hriglse3qlf2pi